Literature DB >> 19738059

Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways.

Martin Puhr1, Frédéric R Santer, Hannes Neuwirt, Martin Susani, Jeffrey A Nemeth, Alfred Hobisch, Lukas Kenner, Zoran Culig.   

Abstract

Suppressor of cytokine signaling-3 (SOCS-3) acts as a negative feedback regulator of the Janus-activated kinase/signal transducers and activators of transcription factors signaling pathway and plays an important role in the development and progression of various cancers. To better understand the role of SOCS-3 in prostate cancer, SOCS-3 expression was down-regulated in DU-145, LNCaP-IL-6+, and PC3 cells by consecutive SOCS-3 small interfering RNA transfections. SOCS-3 mRNA and protein expression as measured by quantitative reverse transcription-PCR and Western blot, respectively, were decreased by approximately 70% to 80% compared with controls. We observed a significant decrease in cell proliferation and viability in all SOCS-3-positive cell lines but not in the parental LNCaP cell line, which is SOCS-3 negative. In this study, we show that down-regulation of SOCS-3 leads to an increased cell death in prostate cancer cell lines. We found a considerable increase in the activation of the proapoptotic caspase-3/caspase-7, caspase-8, and caspase-9. A significant up-regulation of cleaved poly(ADP-ribose) polymerase and inhibition of Bcl-2 expression was observed in all SOCS-3-positive cell lines. Overexpression of Bcl-2 could rescue cells with decreased SOCS-3 levels from going into apoptosis. Tissue microarray data prove that SOCS-3 is highly expressed in castration-refractory tumor samples. In conclusion, we show that SOCS-3 is an important protein in the survival machinery in prostate cancer and is overexpressed in castration-resistant tumors. SOCS-3 knockdown results in an increase of cell death via activation of the extrinsic and intrinsic apoptosis pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19738059     DOI: 10.1158/0008-5472.CAN-09-0806

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

Review 1.  The mutational landscape of prostate cancer.

Authors:  Christopher E Barbieri; Chris H Bangma; Anders Bjartell; James W F Catto; Zoran Culig; Henrik Grönberg; Jun Luo; Tapio Visakorpi; Mark A Rubin
Journal:  Eur Urol       Date:  2013-05-18       Impact factor: 20.096

2.  SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells.

Authors:  Hao Yu; Yudong Liu; Braden C McFarland; Jessy S Deshane; Douglas R Hurst; Selvarangan Ponnazhagan; Etty N Benveniste; Hongwei Qin
Journal:  Cancer Immunol Res       Date:  2015-02-03       Impact factor: 11.151

Review 3.  [Diagnostic of prostate cancer: conventional and molecular or cell biological methods].

Authors:  M Susani; L Kenner; Z Culig
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

4.  Methylation and microRNA-mediated epigenetic regulation of SOCS3.

Authors:  Chandra S Boosani; Devendra K Agrawal
Journal:  Mol Biol Rep       Date:  2015-04       Impact factor: 2.316

5.  miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.

Authors:  Lorenza Pasqualini; Huajie Bu; Martin Puhr; Narisu Narisu; Johannes Rainer; Bettina Schlick; Georg Schäfer; Mihaela Angelova; Zlatko Trajanoski; Stefan T Börno; Michal R Schweiger; Christian Fuchsberger; Helmut Klocker
Journal:  Mol Endocrinol       Date:  2015-06-08

Review 6.  Proinflammatory cytokine interleukin-6 in prostate carcinogenesis.

Authors:  Zoran Culig
Journal:  Am J Clin Exp Urol       Date:  2014-10-02

7.  Expression of interleukin-8 receptor CXCR2 and suppressor of cytokine signaling-3 in astrocytic tumors.

Authors:  Penelope Korkolopoulou; Georgia Levidou; Elias A El-Habr; Christos Adamopoulos; Vassilis Samaras; Athanasios Zisakis; Nikolaos Kavantzas; Efstathios Boviatsis; Paraskevi Fragkou; Athanasios G Papavassiliou; Efstratios Patsouris; Christina Piperi
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

8.  The proinflammatory cytokine, IL-6, and its interference with bFGF signaling and PSMA in prostate cancer cells.

Authors:  Awatef Ben Jemaa; Sataa Sallami; Dunia Ramarli; Marco Colombatti; Ridha Oueslati
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

9.  In vivo identification of solar radiation-responsive gene network: role of the p38 stress-dependent kinase.

Authors:  Nicolas Mouchet; Henri Adamski; Régis Bouvet; Sébastien Corre; Yann Courbebaisse; Eric Watier; Jean Mosser; Christophe Chesné; Marie-Dominique Galibert
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

10.  Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells.

Authors:  Frédéric R Santer; Kamilla Malinowska; Zoran Culig; Ilaria T Cavarretta
Journal:  Endocr Relat Cancer       Date:  2010-02-18       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.